These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22286160)

  • 1. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature.
    Roberto G; Biagi C; Montanaro N; Koci A; Moretti U; Motola D
    Eur J Clin Pharmacol; 2012 Jun; 68(6):1007-11. PubMed ID: 22286160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α1-Adrenergic receptor antagonists and gynecomastia. A case series from the Italian spontaneous reporting system and VigiBase(™).
    Viola E; Opri S; Moretti U; Leone R; Casini ML; Ruggieri S; Minore C; Conforti A
    Eur J Clin Pharmacol; 2014 Aug; 70(8):1003-9. PubMed ID: 24888880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecomastia possibly induced by rosuvastatin.
    Oteri A; Catania MA; Travaglini R; Russo A; Giustini SE; Caputi AP; Polimeni G
    Pharmacotherapy; 2008 Apr; 28(4):549-51. PubMed ID: 18363539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.
    Fernández AB; Karas RH; Alsheikh-Ali AA; Thompson PD
    Chest; 2008 Oct; 134(4):824-830. PubMed ID: 18689579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
    Hoffman KB; Kraus C; Dimbil M; Golomb BA
    PLoS One; 2012; 7(8):e42866. PubMed ID: 22936996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
    Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
    Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase.
    Essers D; Schäublin M; Kullak-Ublick GA; Weiler S
    Eur J Clin Pharmacol; 2019 Mar; 75(3):409-416. PubMed ID: 30430215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and immune-mediated necrotizing myopathy: Variability in the risk.
    Trenque T; Hadjoudj J; Trenque A; Tralongo F; Martin S; Azzouz B
    Therapie; 2024; 79(3):365-370. PubMed ID: 37625939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?
    Sessa M; Rafaniello C; Scavone C; Mascolo A; di Mauro G; Fucile A; Rossi F; Sportiello L; Capuano A
    Expert Opin Drug Saf; 2018 May; 17(5):457-465. PubMed ID: 29619841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy.
    Motola D; Vargiu A; Leone R; Conforti A; Moretti U; Vaccheri A; Velo G; Montanaro N
    Drug Saf; 2008; 31(7):609-16. PubMed ID: 18558794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
    Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
    Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The drugs that mostly frequently induce gynecomastia: A national case - noncase study.
    Batteux B; Llopis B; Muller C; Khouri C; Moragny J; Liabeuf S; Masmoudi K; Gras V;
    Therapie; 2020; 75(3):225-238. PubMed ID: 31471065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golf-inhibiting gynecomastia associated with atorvastatin therapy.
    Hammons KB; Edwards RF; Rice WY
    Pharmacotherapy; 2006 Aug; 26(8):1165-8. PubMed ID: 16863492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.